Cancer Family
Embryonal Neoplasm
CI-CAN-00000013Explore in graph →
Non-malignant285 active trials7 approved drugs73 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000013Explore in graph →
Clinical trials
1,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01586767 | Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy | unknown | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06047535 | Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response. | not yet recruiting | Phase 4 | 62 | SciClone PharmaceuticalsINDUSTRY | 0 | Sep 21, 2023 |
| NCT03860207 | Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers | terminated | Phase 1 / Phase 2 | 12 | Y-mAbs TherapeuticsINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT02998983 | Racotumomab in Patients With High-risk Neuroblastoma | completed | Phase 2 | 39 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Sep 11, 2023 | clinicaltrials |
| NCT01728155 | European Low and Intermediate Risk Neuroblastoma Protocol | completed | Phase 3 | 685 | Instituto de Investigacion Sanitaria La FeOTHER | 10 | Sep 8, 2023 | clinicaltrials |
| NCT02536183 | A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors | terminated | Phase 1 | 2 | AeRang KimOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT01838187 | Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma | no longer available | — | — | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT04854018 | Indo-cyanine Green (ICG) in Paediatric Oncology MIS | completed | Phase 4 | 20 | Birmingham Women's and Children's NHS Foundation TrustOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT01419834 | Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors | completed | Phase 1 | 68 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT04735289 | Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma(Metabol-Sarc) | unknown | — | 810 | Istituto Ortopedico RizzoliOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT04758000 | Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse(Metform-Bone) | recruiting | Phase 2 | 67 | Istituto Ortopedico RizzoliOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05266196 | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | unknown | Phase 1 / Phase 2 | 10 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT02557750 | Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience | unknown | — | 35 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT02558244 | Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study | unknown | — | 100 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT02665676 | Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience | unknown | — | 420 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05100368 | The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma | completed | — | 1,000 | Istituto Ortopedico RizzoliOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05707767 | A Prospective Study of Surgical Treatment Strategies for Chordoma | unknown | N/A | 100 | Xuanwu Hospital, BeijingOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT00788125 | Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors | terminated | Phase 1 / Phase 2 | 7 | City of Hope Medical CenterOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05755295 | Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma(EQUI-HIPPO) | unknown | N/A | 15 | University Hospital, ToulouseOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT01713439 | Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL(CYCHEALL) | completed | Phase 1 | 32 | Baylor College of MedicineOTHER | 1 | Jul 12, 2023 | clinicaltrials |
| NCT05931055 | The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer | not yet recruiting | — | 1,000 | Peking Union Medical College HospitalOTHER | 0 | Jul 5, 2023 | clinicaltrials |
| NCT05918432 | Determining Patterns In Study Experiences of Neuroblastoma Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jun 26, 2023 | clinicaltrials |
| NCT03236857 | A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies | completed | Phase 1 | 143 | AbbVieINDUSTRY | 8 | May 22, 2023 | clinicaltrials |
| NCT03542097 | Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan(MGMTLiberati) | completed | — | 82 | Istituto Ortopedico RizzoliOTHER | 2 | May 15, 2023 | clinicaltrials |
| NCT05850377 | 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas | unknown | — | 90 | Sociedad de Lucha Contra el Cáncer del EcuadorOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05781919 | Use of Virtual Reality for Surgical Planning in Neuroblastoma(VRNB) | unknown | N/A | 130 | Hospital Sant Joan de DeuOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT03495921 | A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide(VITA) | terminated | Phase 3 | 32 | Gradalis, Inc.INDUSTRY | 1 | Apr 26, 2023 | clinicaltrials |
| NCT02444546 | Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors | completed | Phase 1 | 6 | Mayo ClinicOTHER | 1 | Apr 24, 2023 | clinicaltrials |
| NCT00033293 | Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma | completed | Phase 3 | 53 | Children's Oncology GroupNETWORK | 3 | Apr 18, 2023 | clinicaltrials |
| NCT02094625 | NAC to Prevent Cisplatin-induced Hearing Loss | completed | Phase 1 | 52 | Children's Hospital Los AngelesOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT03595228 | BN Brachyury and Radiation in Chordoma | completed | Phase 2 | 29 | Bavarian NordicINDUSTRY | 1 | Apr 14, 2023 | clinicaltrials |
| NCT00005835 | N99-02: Melphalan and Buthionine Sulfoximine(BSO) | completed | Phase 1 | 31 | New Approaches to Neuroblastoma Therapy ConsortiumOTHER | 2 | Apr 10, 2023 | clinicaltrials |
| NCT00084422 | N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma | completed | Phase 1 | 47 | New Approaches to Neuroblastoma Therapy ConsortiumOTHER | 2 | Apr 10, 2023 | clinicaltrials |
| NCT00885326 | N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma | completed | Phase 1 | 29 | New Approaches to Neuroblastoma Therapy ConsortiumOTHER | 2 | Apr 10, 2023 | clinicaltrials |
| NCT01019850 | N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma | completed | Phase 1 | 27 | New Approaches to Neuroblastoma Therapy ConsortiumOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT03110744 | CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma(NCT-PMO-1601) | completed | Phase 2 | 43 | University Hospital HeidelbergOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT04730349 | A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer(PIVOT IO 020) | terminated | Phase 1 / Phase 2 | 15 | Bristol-Myers SquibbINDUSTRY | 6 | Mar 24, 2023 | clinicaltrials |
| NCT05782959 | Phase 1 Study of BCD-245 in Subjects With Neuroblastoma | unknown | Phase 1 | 24 | BiocadINDUSTRY | 1 | Mar 24, 2023 | clinicaltrials |
| NCT03955042 | Pemetrexed for the Treatment of Chordoma | completed | Phase 1 | 15 | Saint John's Cancer InstituteOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT00565903 | Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome(PPB) | completed | — | 1,247 | Ashley HillOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT01590680 | Expanded Access Protocol Using 131I-MIBG | available | — | — | Jubilant DraxImage Inc.INDUSTRY | 1 | Feb 28, 2023 | clinicaltrials |
| NCT02431715 | 18F-FDOPA PET in Neuroendocrine Tumours | no longer available | — | — | British Columbia Cancer AgencyOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04334863 | WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors | completed | Phase 1 | 10 | Emory UniversityOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT03561259 | A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects(OPTIMUM) | unknown | Phase 2 | 60 | Jubilant DraxImage Inc.INDUSTRY | 1 | Feb 16, 2023 | clinicaltrials |
| NCT04661852 | Cabozantinib With Topotecan-Cyclophosphamide | completed | Phase 1 | 12 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT04956198 | Drug Sensitivity and Mutation Profiling | completed | — | 14 | Florida International UniversityOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT03655587 | Impact of an Orthotic Intervention in Children With Peripheral Neuropathy(IOPN) | completed | N/A | 27 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT03273712 | Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) | completed | Phase 2 | 39 | University of IowaOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT05406947 | Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children | not yet recruiting | — | 350 | Beijing Tiantan HospitalOTHER | 0 | Feb 8, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Sep 21, 2023source: clinicaltrials